Acumen Pharmaceuticals (ABOS)

Acumen Pharmaceuticals (ABOS) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• ABOS last traded at $0.21, -90.83% on the day.
• Acumen Pharmaceuticals: P/E -0.2.
• Over the past year ABOS returned -90.54%; year to date -90.04%.

Updated 2026-11-02 18:23 UTC